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Trehalose synthase (TreS) was thought to catalyze
flux from maltose to trehalose, a precursor of essen-
tial trehalose mycolates in mycobacterial cell walls.
However, we now show, using a genetic approach,
that TreS is not required for trehalose biosynthesis
in Mycobacterium smegmatis, whereas two alterna-
tive trehalose-biosynthetic pathways (OtsAB and
TreYZ) are crucial. Consistent with this direction of
flux, trehalose levels in Mycobacterium tuberculosis
decreased when TreS was overexpressed. In addi-
tion, TreS was shown to interconvert the a anomer
of maltose and trehalose using 1H and 19F-nuclear
magnetic resonance spectroscopies using its normal
substrates and deoxyfluoromaltose analogs, with
the nonenzymatic mutarotation of a/b-maltose
being slow. Therefore, flux through TreS inmycobac-
teria flows from trehalose to a-maltose, which is
the appropriate anomer for maltose kinase of the
GlgE a-glucan pathway, which in turn contributes
to intracellular and/or capsular polysaccharide
biosynthesis.
INTRODUCTION
Trehalose (a-D-glucopyranosyl-(1/1)-a-D-glucopyranoside) is
a nonreducing disaccharide that has many roles in biology
(Argu¨elles, 2000; Elbein et al., 2003; Paul et al., 2008). For
example, it is a precursor for cell wall trehalose mycolates (Fig-
ure 1A) that are essential for the growth and virulence of myco-
bacteria, such as Mycobacterium tuberculosis (Takayama
et al., 2005), the causative agent of the globally widespread
human disease tuberculosis (Dye, 2006). For this reason, treha-
lose has attracted attention in the development of imaging
agents (Backus et al., 2011; Swarts et al., 2012) and drugs (Lin
et al., 2007; Rose et al., 2002;Wang et al., 2004) to help diagnose
and treat tuberculosis. It has been widely thought that there are
three pathways responsible for the biosynthesis of trehalose in
mycobacteria (Figure 1A): the OtsAB, TreYZ, and trehalose syn-
thase (TreS) pathways (Avonce et al., 2006; Elbein et al., 2003).Chemistry & Biology 20,In vitro experiments have shown that all three pathways could,
in principle, operate in mycobacteria (De Smet et al., 2000). In
addition, genetic experiments appeared to show that all path-
ways are capable of synthesizing trehalose de novo in the fast-
growing avirulent speciesMycobacterium smegmatis (Woodruff
et al., 2004). By contrast, it has been reported that the OtsAB
pathway is dominant in trehalose biosynthesis inMycobacterium
tuberculosis and that TreS could have a role only in late-stage
pathogenesis in infected mice (Murphy et al., 2005). This implies
Mycobacterium smegmatis is not an appropriate model organ-
ism with respect to the metabolism of trehalose in Mycobacte-
rium tuberculosis. The picture is complicated further by evidence
that only the OtsAB and TreYZ pathways, but not the TreS
pathway, appear to be important in the de novo biosynthesis
of trehalose and trehalose mycolate formation in the related acti-
nomycete, Corynebacterium glutamicum (Tzvetkov et al., 2003;
Wolf et al., 2003).
TreS is a maltose a-D-glucosylmutase (EC 5.4.99.16) that
interconverts maltose (a-D-glucopyranosyl-(1,4)-D-glucopyra-
nose) and trehalose (Nishimoto et al., 1995; Pan et al., 2004).
Therefore, an oft ignored puzzle has been the lack of an obvious
and significant source of maltose in amycobacterium either from
its own metabolism or its environment. This is compounded by
the lack of a maltose transporter inMycobacterium tuberculosis
(Kalscheuer et al., 2010a). However, we recently discovered an
alternative route for a-glucan biosynthesis, the GlgE pathway,
which is widespread among bacteria and involves the consump-
tion of trehalose by TreS (Chandra et al., 2011; Kalscheuer et al.,
2010b). These observations prompt the question as to whether
TreS contributes to the biosynthesis of either trehalose myco-
late, a-glucans, or both in mycobacteria.
There are no reports of experimental evidence defining the
anomeric configuration of maltose that TreS produces. The
configuration could have consequences for metabolic flux,
because the nonenzymatic mutarotation of maltose is so slow
that the half-life of anomeric equilibration is of the order of tens
of minutes (Bailey et al., 1967). Furthermore, although maltose
mutarotase enzymes are known, they appear to be rare and
have only been detected in higher plants (Bailey et al., 1967)
and Lactobacillus brevis (Shirokane and Suzuki, 1995). TreS is
a glycoside hydrolase GH13_3 (Stam et al., 2006) family member
according to the CaZy database (Cantarel et al., 2009). Thus, it is
predicted to have a (b/a)8 fold, defining an active site containing
an Asp nucleophile and a Glu proton donor that catalyze an487–493, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 487
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Figure 1. Metabolism of Trehalose in Myco-
bacteria and Proposed Mechanism of TreS
(A) All known metabolic pathways associated with
trehalose in mycobacteria are shown, except for
its hydrolysis by trehalase to form glucose as a
carbon source for growth (Carroll et al., 2007). The
questions addressed by this work are indicated in
boxes.
(B) Proposed catalytic mechanism of TreS with
the most likely relative orientations of the glucose
rings of trehalose and maltose. Hydrolysis would
be expected to occur when water attacks
the glucosyl-enzyme intermediate, generating a
second glucose molecule with an a anomeric
configuration.
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Trehalose Synthase Makes a-Maltose in Mycobacteriaa-retaining double-displacement reaction mechanism (Fig-
ure 1B). In support of this mechanism, evidence for the gluco-
syl-enzyme intermediate involving Asp230 in theMycobacterium
smegmatis enzyme has been reported recently (Zhang et al.,
2011). One would therefore predict that a-maltose is utilized
and produced by TreS, but evidence to support this notion is
currently lacking.
We now show, using a genetic approach, that flux through
TreS is from rather than to trehalose in both Mycobacterium
smegmatis and Mycobacterium tuberculosis. Therefore, TreS
supplies intermediates for the GlgE a-glucan pathway rather
than the trehalose mycolate pathway, both potential targets for
imaging agents and therapeutic inhibitors. Furthermore, we
show using 1H-nuclear magnetic resonance (NMR) spectros-
copy, supported by 19F-NMR spectroscopy and deoxyfluoro
substrate analogs, that the appropriate a anomer of maltose is
formed for maltose kinase of the GlgE pathway. These findings
have implications for the study and targeting of trehalose-depen-
dent pathways in mycobacteria and other bacteria.
RESULTS
Characterization of Trehalose Auxotrophs
of Mycobacterium Smegmatis
In order to definitively assess the contribution of TreS for the de
novo biosynthesis of essential trehalose in mycobacteria, we
generated site-specific gene deletion mutants inMycobacterium
smegmatis in the three reported trehalose biosynthetic pathways
by targeting the genes treS, otsA, and treY1-treY2-treZ, both
individually and in combination (Figure S1 available online).488 Chemistry & Biology 20, 487–493, April 18, 2013 ª2013 Elsevier Ltd All rights reservedInactivation of treS alone or in combina-
tion with either otsA or treYZ did not
lead to any detectable growth defect in
the absence of exogenous trehalose (Fig-
ure 2A). In contrast, we found that not only
the DtreS(u)DotsA(u)DtreYZ triple mutant
but also the DotsA(u)DtreYZ double
mutant strictly required trehalose supple-
mentation for growth on solid medium
(Figure 2B) and in liquid culture (Fig-
ure 2C), despite the double mutant
possessing an intact treS gene. Supple-
mentation with exogenous trehalose inthe mM range was sufficient to support growth of these two
trehalose auxotrophs (Figure 2C), showing that TreS does not
contribute significantly to the de novo production of trehalose
inMycobacterium smegmatis. In the absence of trehalose, exog-
enous maltose in the mM range could partially restore growth of
the DotsA(u)DtreYZ but not the DtreS(u)DotsA(u)DtreYZ mutant
(Figure 2D). These data indicate that TreS could be capable of
synthesizing trehalose in mycobacteria but that the biosynthesis
of maltose is severely limited in the growth conditions tested.
TreS Consumes Trehalose in Mycobacterium
Tuberculosis
In order to assess the direction of flux through TreS inMycobac-
terium tuberculosis, we analyzed intracellular trehalose levels in
Mycobacterium tuberculosis wild-type, the DtreS mutant and
treS-overexpressing strains (Figure 2E). Deletion of treS had no
influence on the intracellular trehalose concentration, precluding
the ability to distinguish between TreS having a role in trehalose
formation and consumption. However, the intracellular trehalose
level in the treS-overexpressing strain was dramatically reduced,
which indicates that TreS has a role in the consumption of treha-
lose inMycobacterium tuberculosis, a direction of flux consistent
with that in Mycobacterium smegmatis.
TreS Interconverts Trehalose with the a Anomer
of Maltose According to 1H-NMR Spectroscopy
With a view to establishing whether TreS interconverts the a
anomer of maltose, we explored the use of 1H-NMR spectros-
copy. A spectrum of a reaction mixture generated from maltose
by TreS allowed each component to be detected (Figure S2A),
Figure 2. The TreS Pathway Does Not
Contribute to the De Novo Biosynthesis of
Trehalose in Mycobacteria
(A) Trehalose growth requirements in liquid culture
of Mycobacterium smegmatis gene deletion
mutants (see Figure S1 for how they were gener-
ated). Cultures were incubated for 48 hr at 37C in
Middlebrook 7H9 medium containing 0.5% (v/v)
glycerol and 10% (v/v) albumin-dextrose-saline
(ADS) enrichment containing either 0 or 50 mM
trehalose. Values are means of triplicates ± SD.
(B) Trehalose growth requirements on solid media
of the trehalose-auxotrophic Mycobacterium
smegmatis mutants DotsA(u)DtreYZ and DtreS(u)
DotsA(u)DtreYZ. Cells were cultivated for 72 hr on
Middlebrook 7H10 agar containing 0.5% (v/v)
glycerol and 10% (v/v) ADS enrichment in the
presence or absence of 100 mM trehalose.
(C) Trehalose growth requirements in liquid culture
of the trehalose-auxotrophic Mycobacterium
smegmatis mutants DotsA(u)DtreYZ and DtreS(u)
DotsA(u)DtreYZ. Growth conditions were essen-
tially as described for (A) with 0–50 mM trehalose.
(D) Maltose supplementation of trehalose auxo-
trophic Mycobacterium smegmatis gene deletion
mutants. Growth conditions were essentially
as described for (A) without trehalose but
with 0–10 mM maltose. Values are means of
triplicates ± SD.
(E) Effect of treS deficiency and overexpression on
intracellular trehalose concentration in Mycobac-
terium tuberculosis. Cultures of Mycobacterium
tuberculosis H37Rv wild-type, the DtreS mutant
and a treS overexpressing strain (wild type [WT] +
treS) were incubated for 14 days in Middlebrook
7H9 medium containing 0.5% (v/v) glycerol and
10% (v/v) oleic acid-albumin-dextrose-catalase
enrichment before enzymatically determining
trehalose concentrations. Values are means of
sextuplicates ± SD.
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Trehalose Synthase Makes a-Maltose in Mycobacteriaincluding glucose, a known product of hydrolysis (Nishimoto
et al., 1996; Pan et al., 2004; Zhang et al., 2011), and the anomers
of each reducing sugar. Since anomers mutarotate non-
enzymatically, their equilibration upon dissolution of crystalline
materials in citrate buffer at 25C was monitored using 1H-
NMR spectroscopy (Figure S2B). The rate constants determined
for the mutarotation of a-glucose to b-glucose and the reverse
reaction were 0.0316 ± 0.0004 and 0.0192 ± 0.0004 min1
and, for maltose, 0.0286 ± 0.0002 and 0.0187 ± 0.0001 min1,
each respectively (Figure S2C). These rate constants were
consistent with the literature (Bailey et al., 1967; Stults et al.,
1987) and the expected dominance of the b anomers.
The conversion of trehalose into maltose by TreS in citrate
buffer as a function of time was monitored using 1H-NMR spec-
troscopy (Figure 3A). The a anomer of maltose was formed
5.4-fold more rapidly than its b anomer, suggesting TreS gener-
ates the a anomer. A low level of glucose was also producedChemistry & Biology 20, 487–493, April 18, 2013through hydrolysis, as observed previ-
ously. At longer times, the ratio between
trehalose and a/b-maltose was 2.2:1 (at
25C and pH 6.7), which is reasonably
similar to the equilibrium position of 4.6:1 determined from the
free energies of hydrolysis of these disaccharides (at 25C and
pH 5.65) (Syson et al., 2011; Tewari and Goldberg, 1991; Tewari
et al., 2008) and of 3.2:1 determined from the kinetics of Myco-
bacterium smegmatis TreS (Zhang et al., 2011). The expected
equilibrium positions between the anomers of both maltose
and glucose were also approached at longer times.
As TreS formed trehalose from pre-equilibrated a/b-maltose
(a:b anomeric ratio of 1:1.5), a rapid depletion of a-maltose
was immediately apparent (Figure 3B). By contrast, the con-
sumption of b-maltose was significantly slower and conformed
to a single exponential function (Figure S2D) with a rate of
0.019 min1 that was consistent with the rate constant for the
mutarotation described above (0.0187 ± 0.0001 min1). This
implied that TreS does not utilize the b anomer. When the exper-
iment was repeated with lower TreS concentrations, the rate of
consumption of a-maltose decreased, while that of the b anomerª2013 Elsevier Ltd All rights reserved 489
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Figure 3. Mycobacterium Tuberculosis
TreS Interconverts the a Anomer of Maltose
(A) The conversion of trehalose (10 mM) into
maltose by TreS (2 mM) according to 1H-NMR
spectroscopy (see Figures S2A–S2C for repre-
sentative spectra and nonenzymic mutarotation
controls). Each component was quantified by
signal integration using citrate as an internal
standard. Reaction mixtures contained 10% D2O
to assist spectrum acquisition without significant
risk of introducing solvent kinetic and/or equilib-
rium isotope effects. This necessitated solvent
suppression and the introduction of experimen-
tally determined correction factors for the cosup-
pression of resonances that were close to the
solvent resonance.
(B) The conversion of pre-equilibrated a/b-maltose
(10 mM) into trehalose by TreS (2 mM) according to
1H-NMR spectroscopy. Note that enzyme was
added immediately after the t = 0 data were ac-
quired, resulting in a small and reproducible
change in the apparent concentration of starting
materials at the second recorded time point. See
Figure S2D for the fit of the b-maltose curve
(Hoops et al., 2006). The times taken to produce
2 mM trehalose and consume 50% of the
a/b-maltose were 14 and 55 min, respectively.
(C) Time courses of the ratios between the b and a
anomers of maltose with different TreS concen-
trations during the conversion of pre-equilibrated
a/b-maltose. The broken line indicates the equilib-
rium between the two anomers in these conditions.
(D) Proposed reaction scheme to account for
TreS-catalyzed reactions. Protons used to quan-
tify components of the reaction mixtures by
1H-NMR spectroscopy (Figure S2A) are indicated.
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Trehalose Synthase Makes a-Maltose in Mycobacteriaremained similar. Thus, the transient increase in the b/a ratio of
themaltose anomerswas less pronounced at lower enzyme con-
centrations (Figure 3C), providing further evidence that TreS con-
verts only the a anomer of maltose into trehalose, as expected.
While the initial formation of glucose through hydrolysis ap-
peared to be more rapid from maltose than trehalose, this most
likely reflected the more rapid initial consumption of maltose.
This implies the equal probability of either a-maltose or trehalose
being hydrolyzed. It is also noteworthy that the a anomer of
glucose was produced more rapidly from maltose than its b
anomer, suggesting that a-glucose is the product of hydrolysis.
The Specificity of TreS for the a Anomer of Maltose
Is Retained with Deoxyfluoro Analogs According
to 19F-NMR Spectroscopy
Deoxyfluorotrehalose analogs have been shown to label Myco-
bacterium tuberculosis cells and exhibit weak antimycobacterial
activity (Backus et al., 2011). SinceMycobacterium tuberculosis
has a trehalose transporter (Kalscheuer et al., 2010a) and TreS
has been reported to utilize 2-fluoro-2-deoxymaltose as a sub-
strate (Zhang et al., 2011), the ability of TreS to convert 2-, 3-,
and 6-deoxyfluoromaltose analogs (Tantanarat et al., 2012)
was monitored using 19F-NMR spectroscopy (Figure 4). The
2-deoxy-2-fluoro and 6-deoxy-6-fluoro compounds were con-
verted to the corresponding deoxyfluorotrehalose analogs
2-fold and 180-fold less efficiently than the normal substrate490 Chemistry & Biology 20, 487–493, April 18, 2013 ª2013 Elsevier(Figures 4A and 4C). The hydrolysis of each analog to the corre-
sponding deoxyfluoroglucose compounds was detected (Fig-
ures 4A–4C), particularly with the 3-fluoro-3-deoxy and
6-fluoro-6-deoxy compounds, with the former being exclusively
hydrolyzed (Figure 4B). The expected concomitant formation of
nonfluorinated glucose was detected using 1H-NMR spectros-
copy (data not shown). The a anomer was consumed more
rapidly than the b anomer with all three analogs (Figures 4A–
4C), consistent with TreS only acting on a anomers. The mutaro-
tation rates of the deoxyfluoro analogs are not known, but fitting
the decay of the b anomer of the 2-deoxy-2-fluoro analog (Fig-
ure 4A) suggested a rate constant of 0.004 min1, an order of
magnitude slower than that for maltose.
In order to assess whether fluoro substitution at the three and
six positions resulted in poor binding to TreS or slow conversion
by TreS, the extent of conversion of 0.52 mM 2-deoxy-2-fluoro-
maltose was monitored in the presence and absence of 2.1 mM
of each of the other two analogs (Figure S3D). Neither of the
analogs gave inhibition, and there may indeed have been a
modest stimulation of activity. Given that the Km for maltose is
8–10 mM with the Mycobacterium smegmatis enzyme (Pan
et al., 2004; Zhang et al., 2011) and the Km for the 2-deoxy-2-
fluoro analog would not be expected to be orders of magnitude
lower than this, the lack of inhibition is consistent with fluoro sub-
stitution at the three and six positions, compromising the ability
of maltose analogs to bind to TreS.Ltd All rights reserved
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Figure 4. Mycobacterium Tuberculosis
TreSConverts the aAnomers of Deoxyfluor-
omaltose Analogs
(A) The conversion of pre-equilibrated 2-deoxy-2-
fluoro-a/b-maltose (10 mM) by TreS (2 mM) was
monitored using 19F-NMR spectroscopy (see
Figure S3A for spectra). The times taken to
produce 2 mM 2-deoxy-2-fluorotrehalose and
consume 50% of the maltose analog were 25 and
125 min, respectively, both 2-fold longer than
with maltose.
(B) Corresponding data with 3-deoxy-3-fluoro-
a/b-maltose (Figure S3B). The time taken to con-
sume 50% of the maltose analog was 1,100 min,
20-fold longer than with maltose. No 3-deoxy-3-
fluorotrehalose was detected.
(C) Corresponding data with 6-deoxy-6-fluoro-
a/b-maltose (Figure S3C). The times taken to
produce 2 mM 6-deoxy-6-fluorotrehalose and
consume 50% of the maltose analog were 2,500
and 1,500 min, respectively, 180- and 27-fold
longer than with maltose.
(D) Proposed reaction scheme to account for the
conversion of deoxyfluoromaltoses by TreS.
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We have shown that the direction of flux through TreS is from
trehalose to maltose and that the source of trehalose is a combi-
nation of the OtsAB and TreYZ pathways in Mycobacterium
smegmatis (Figure 2). The overexpression of TreS led to a
decrease in trehalose levels, indicating the same direction of
flux in Mycobacterium tuberculosis. Thus, TreS appears not to
generate trehalose for trehalose mycolate biosynthesis but to
convert trehalose intomaltose for theGlgE pathway inmycobac-
teria (Elbein et al., 2010; Kalscheuer et al., 2010b). Although the
equilibrium of the TreS-catalyzed reaction is not in line with
the direction of flux, the ATP requirement of maltose kinase for
the formation of a-maltose 1-phosphate provides most of the
driving force through the GlgE pathway, as discussed elsewhere
(Syson et al., 2011). Consistent with this, exogenously supplied
14C-labeled trehalose is rapidly and substantially converted to
a-maltose 1-phosphate in a Mycobacterium smegmatis DglgE
mutant, with maltose only being detected when the pep2
maltose kinase gene was inactivated (Kalscheuer et al.,
2010b). The observed direction of flux contrasts with a previous
study inMycobacterium smegmatis (Woodruff et al., 2004). How-
ever, the authors did not employ a defined DotsADtreY double
mutant to study the specific contribution of TreS in the de novo
biosynthesis of trehalose but rather a surrogate strain (a DotsAD
treSDtreY triple mutant with a reconstituted treS gene constitu-
tively expressed from an episomal multicopy plasmid) that likelyChemistry & Biology 20, 487–493, April 18, 2013exhibited a much higher treS expression
level compared with the native gene.
Moreover, as nonspecified culture condi-
tions were used, it is unclear whether the
medium was devoid of maltose, which
might be sufficient to support growth in
this genetic context in the absence of
trehalose. In any case, our observationsare consistent with those of others in Mycobacterium tubercu-
losis (Murphy et al., 2005) and Corynebacterium glutamicum
(Tzvetkov et al., 2003; Wolf et al., 2003). Thus, we have shown
that the metabolism of trehalose in Mycobacterium smegmatis
is similar to that inMycobacterium tuberculosis after all, allowing
Mycobacterium smegmatis to be used as a model organism in
this context. Furthermore, our Mycobacterium smegmatis
strains, particularly the strains that are auxotrophic for trehalose,
could be used to study the impact of trehalose analogs on spe-
cific pathways. It is also intriguing that TreS may be important in
late-stage pathogenesis in mice (Murphy et al., 2005), implying a
potential role of GlgE pathway-generated cytosolic and/or
capsular a-glucan in this process, noting that the latter has
been implicated in immune evasion (Sambou et al., 2008).
TreS generates the appropriate a anomer for maltose kinase
(Drepper et al., 1996; Mendes et al., 2010) of the GlgE pathway
(Kalscheuer et al., 2010b). Thus, the formation of a-maltose
1-phosphate is not limited by the mutarotation of maltose in
mycobacteria. This is relevant to many other species, because
the treS gene coexists with the other genes of the GlgE pathway
in 14% of all sequenced bacterial genomes (Chandra et al.,
2011). In a further 28% of genomes that possess the treS
gene, one or more of the other GlgE pathway genes is missing.
It is therefore not possible to rule out that flux through TreS favors
the conversion of maltose to trehalose in organisms that have
access to sufficient cytosolic maltose from intracellular or extra-
cellular sources. If the maltose were generated by an enzymeª2013 Elsevier Ltd All rights reserved 491
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Trehalose Synthase Makes a-Maltose in Mycobacteriasuch as b-amylase, themutarotation of b-maltose could become
an issue for flux through TreS to trehalose. Indeed, this work
highlights that the mutarotation of any given reducing sugar
should not be assumed to be fast comparedwith themetabolism
of a specific sugar anomer.
It is now possible to propose schemes defining the anomeric
configurations and origins of all species associated with the
TreS-catalyzed reactions studied (Figures 3D and 4D). TreS in-
terconverts the a anomer of maltose (Figures 3A–3C) as
expected (Figure 1B), and specificity was also retained with
deoxyfluoro analogs (Figures 4A–4C). The TreS enzyme is
thought to sterically capture the glucose molecule that it liber-
ates (Figure 1B) and transiently exclude access to the active
site such that exogenously supplied glucose does not get incor-
porated into the products of TreS (Koh et al., 2003; Nishimoto
et al., 1996; Zhang et al., 2011). Thus, TreS catalyzes an isomer-
ization, whereby the noncovalently captured glucose molecule
must rotate within an enclosed active site. We have now estab-
lished that this glucose molecule retains its a configuration,
whether it goes on to produce normal disaccharide products
or is released in the hydrolytic side reaction. Therefore, TreS cat-
alyzes the mutarotation of neither maltose nor glucose.
Unlike trehalose, the deoxyfluorotrehalose products are
asymmetric and might have been converted to the correspond-
ing n0-deoxy-n0-fluoromaltose analogs but were not (Figure 4D).
This could have been due to the destabilization of oxocarbenium
ion-like transition states associatedwith these reactions (Withers
et al., 1988). Alternatively, other effects could be involved, such
as reduced binding affinities. Indeed, neither of the 3-deoxy-3-
fluoro and 6-deoxy-6-fluoromaltose analogs appeared to bind
well to the enzyme. That 3-deoxy-3-fluoromaltose was exclu-
sively hydrolyzed means that 3-deoxy-3-fluoroglucose is less
able than a water molecule to attack the glucosyl-enzyme inter-
mediate. This could be due to changes in the nucleophilicity of
3-deoxy-3-fluoroglucose or more likely to an inability to orient
itself appropriately within the active site.
SIGNIFICANCE
Our findings about the flux through TreS to supply the
trehalose mycolate and a-glucan biosynthetic pathways
(Figure 1A) have implications for the design and efficacy of
inhibitors/imaging agents that target them (Backus et al.,
2011; Swarts et al., 2012). It is now much clearer which en-
zymes need to be targeted to affect either one or both of
these pathways. Furthermore, substrate analogs can now
be designed as prodrugs for a given pathway that avoid
detoxification by competing pathways. For example, when
targeting the synthesis of essential trehalose mycolates
(Backus et al., 2011; Swarts et al., 2012), it would be an
advantage if trehalose analogs were not converted and de-
activated by TreS. Indeed, we have observed the limited
ability of TreS to tolerate relatively small modifications of
its substrates. However, when targeting GlgE or GlgB
(Kalscheuer and Jacobs, 2010), there is the challenge of a
trehalose analog being tolerated by not only TreS but also
the trehalose importer (Kalscheuer et al., 2010a) andmaltose
kinase. Therefore, the weak inhibition of the growth of
Mycobacterium tuberculosis by either 2-deoxy-2-fluoro or492 Chemistry & Biology 20, 487–493, April 18, 2013 ª2013 Elsevier6-deoxy-6-fluoromaltose (Backus et al., 2011) could be due
to a lack of either import, efficient processing, and/or inhibi-
tion of the GlgE/GlgB targets. Interestingly, labeling of
Mycobacterium smegmatis using a 4-azido analog of
trehalose is TreS-dependent (Swarts et al., 2012). This
observation implies the tolerance of this analog through
each step in the biosynthesis of capsular a-glucan rather
than trehalose mycolates. Our work supports this interpre-
tation and also shows that this observation in Mycobacte-
rium smegmatis is likely to be relevant to Mycobacterium
tuberculosis.EXPERIMENTAL PROCEDURES
All details about the Experimental Procedures used are given in the Supple-
mental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.chembiol.2013.02.014.
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